Q1 2011

Filed May 13, 2011 · 10-Q · 43 days after period end · 0001144204-11-028959

Q1 2011 · 10-Q

Revenue—

Net Income

-$705.00K

no prior Q1 2010 on file

EPS, diluted—

Operating Income$705,000—

Operating Cash Flow-$55,000—

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Mar 31, 2011 · filed May 13, 2011 · 43 d after period end

Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR